I3 Pharms Company Profile
✉ Email this page to a colleague
What is the competitive landscape for I3 PHARMS, and what generic and branded alternatives to I3 PHARMS drugs are available?
I3 PHARMS has five approved drugs.
Drugs and US Patents for I3 Pharms
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
I3 Pharms | ZAROXOLYN | metolazone | TABLET;ORAL | 017386-003 | Approved Prior to Jan 1, 1982 | DISCN | Yes | No | ⤷ Try a Trial | ⤷ Try a Trial | |||||
I3 Pharms | RANOLAZINE | ranolazine | TABLET, EXTENDED RELEASE;ORAL | 213517-002 | Apr 27, 2022 | AB | RX | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ||||
I3 Pharms | SELEGILINE HYDROCHLORIDE | selegiline hydrochloride | TABLET;ORAL | 074672-001 | Apr 1, 1997 | AB | RX | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ||||
I3 Pharms | ISOSORBIDE DINITRATE AND HYDRALAZINE HYDROCHLORIDE | hydralazine hydrochloride; isosorbide dinitrate | TABLET;ORAL | 215988-001 | Jan 17, 2024 | AB | RX | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Similar Applicant Names
Here is a list of applicants with similar names.